---
schema_version: "secwatch.filing_event.v1"
accession: "0001295947-24-000030"
form_type: "8-K"
ticker: "PBH"
cik: "0001295947"
company_name: "Prestige Consumer Healthcare Inc."
filed_at: "2024-11-07T23:59:59+00:00"
generated_at: "2026-05-30T03:20:36.144555+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Prestige Consumer Healthcare Q2 revenue $283.8M, diluted EPS $1.09; reaffirms FY2025 outlook

## Summary
- Revenue $283.8M (-0.9% YoY) slightly ahead of expectations; diluted EPS $1.09 vs $1.07 prior year.
- North American OTC down 1.9% to $239.8M; International OTC up 5.0% to $44.0M driven by Hydralyte.
- Free cash flow $67.8M in Q2; net cash from operations $69.8M, up 11.7% YoY.
- Repurchased ~0.2M shares for $12M in Q2; reduced debt by $75M YTD; leverage ratio 2.7x.
- Reaffirmed FY2025 outlook: revenue $1,125-1,140M, adj. diluted EPS $4.40-4.46, free cash flow $240M+.

## SEC filing metadata
- accession: 0001295947-24-000030
- form_type: 8-K
- ticker: PBH
- cik: 0001295947
- company_name: Prestige Consumer Healthcare Inc.
- filed_at: 2024-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1295947/000129594724000030/0001295947-24-000030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1295947/000129594724000030/pbh-20241107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001295947-24-000030
- JSON: https://secwatch.observer/filing/0001295947-24-000030.json
- Plain text: https://secwatch.observer/filing/0001295947-24-000030.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.